Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1) - Schmitz, N; Nickelsen, M; Ziepert, M (Lancet Oncol, 2012)
. doi:10.1016/S1470-2045(12)70481-3